The writer is former chairman, Competition Commission of India
October 28, 2024 04:05 IST
As seen in the ongoing controversy surrounding pertuzumab, despite legal safeguards, evergreening remains an issue in launching affordable biosimilars.
February 18, 2021 20:49 IST
By providing startups the right regulatory architecture and local sources of funding, India can create an innovative and resilient economy
December 03, 2016 00:04 IST
The digital economy calls for a new kind of oversight
